ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

ClinicalTrials.gov ID: NCT01800968

Public ClinicalTrials.gov record NCT01800968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Functional Impact of GLP-1 for Heart Failure Treatment

Study identification

NCT ID
NCT01800968
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Duke University
Other
Enrollment
300 participants

Conditions and interventions

Interventions

  • Liraglutide Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2013
Primary completion
Sep 30, 2015
Completion
Sep 30, 2015
Last update posted
Feb 14, 2017

2013 – 2015

United States locations

U.S. sites
25
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Christiana Care Health Services Newark Delaware 19718
Emory University School of Medicine Atlanta Georgia 30322
Northwestern University Chicago Illinois 60611
Johns Hopkins Hospital Baltimore Maryland 21287
Tufts Medical Center Boston Massachusetts 02111
Massachusetts General Hospital Boston Massachusetts 02114
Brigham and Women's Hospital Boston Massachusetts 02115
Boston VA Healtcare System West Roxbury Massachusetts 02132
Mayo Clinic Rochester Minnesota 55905
Washington University St Louis Missouri 63110
Saint Louis University Hospital St Louis Missouri 63117
Duke University Durham North Carolina 27705
Southeast Regional Medical Center Lumberton North Carolina 28538
University Hospitals- Case Medical Center Cleveland Ohio 44106
Metro Health System Cleveland Ohio 44109
Cleveland Clinic Cleveland Ohio 44195
Lancaster Heart and Stroke Foundation Lancaster Pennsylvania 17603
University of Pennsylvaina Philadelphia Pennsylvania 19104
Jefferson Medical College Philadelphia Pennsylvania 19107
Temple University Hospital Philadelphia Pennsylvania 19140
Michael Debakey VA Medical Center Houston Texas 77030
Intermountain Medical Center Murray Utah 84157
University of Utah School of Medicine Salt Lake City Utah 84132
Utah VA Medical Center Salt Lake City Utah 84132
The University of Vermont- Fletcher Allen Health Care Burlington Vermont 05401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01800968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 14, 2017 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01800968 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →